Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Part D Reform Proposals From MedPAC May Find Traction After Election

This article was originally published in The Pink Sheet Daily

Executive Summary

Advisory group’s cost control recommendations on reinsurance, partial fills, and preferred specialty tiers could end up on the legislative agenda, particularly if Hillary Clinton is president.

You may also be interested in...



Medicare Part D Payment Model Gives Health Plans More Incentives To Negotiate Lower Drug Prices

Participating plans to share in savings if they stay below spending target for Part D catastrophic phase and repay 10% of any excess spending; CMS also updates its VBID model.

Medicare Part D Catastrophic Spending Surge Needs Solutions, OIG Says

HHS Office of Inspector General joins legislators and policy experts in warning about sharp increases in Medicare spending on catastrophic coverage in Part D.

Price Increases Accounted For Over Half Of Drug Spending Growth In 2015

CMS National Health Expenditures report finds continued double-digit growth rates for retail prescription drug spending in Medicare and Medicaid.

Related Content

Topics

UsernamePublicRestriction

Register

PS079518

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel